A Phase I/II Study of XELIRI Plus Bevacizumab as Second-Line Chemotherapy for Japanese Patients With Metastatic Colorectal Cancer (BIX Study)

BACKGROUND. Capecitabine is used mainly with oxaliplatin to treat metastatic colorectal cancer (mCRC). Results from capecitabine plus irinotecan (XELIRI) with or without bevacizumab (BV) have been reported in Europe but not in Japan. Consequently, the safety and efficacy of XELIRI plus BV in Japanes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Hamamoto, Yasuo, Yamaguchi, Tatsuro, Nishina, Tomohiro, Yamazaki, Kentaro, Ura, Takashi, Nakajima, Takako, Goto, Ayumu, Shimada, Ken, Nakayama, Norisuke, Sakamoto, Junichi, Morita, Satoshi, Yamada, Yasuhide
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221367/
https://ncbi.nlm.nih.gov/pubmed/25280489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados